Gilead Sciences said on Saturday that it entered into a partnership with Denmark’s LEO Pharma to develop programs to treat patients with inflammatory diseases.
Trending
- Enola Holmes 3 Trailer Teases Maltese Mystery For Millie Bobby Brown
- Bach’s music as hit parade
- 100 years after Gaudí's death, the Sagrada Família rises
- Teyana Taylor gives Chanel the Harlem treatment
- Chanel Taps Marie-Laure Cérède as Director of Jewelry Creation Studio
- These will be the fashion colors of summer 2026
- French industry rallies around Israeli filmmaker Nadav Lapid following forced withdrawal from FID Marseille | News
- Oude en nieuwe Belgische mode in de etalage: Antwerp Fashion Festival
Gilead, LEO Pharma partner to develop programs for inflammatory diseases
By Reuters Econ
